About Peter Tollman
Form D filings for Diasome Pharmaceuticals from 2023 to 2024 list Peter Tollman as director.
Peter Tollman first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Peter Tollman in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Peter Tollman works with at each company, as listed on that company's latest Form D.
Diasome Pharmaceuticals, Inc. · Form D, Aug 15, 2024
RG
Robert Geho
Chief Executive Officer and director
FM
Frank McCaney
Director
WG
W. Geho
Executive officer and director
TM
Thomas McDonald
Director
CO
Cosme Ordonez
Director